KPI data tables
Constellation Software operating metrics behind the KPI charts, newest period first (up to 24 periods per chart). Periods use each company's own fiscal labels where the source does; each table names its source.
| Period | Reported organic | FX-adjusted organic |
|---|---|---|
| Q3 2026 | 2 | 2 |
| Q2 2026 | 3 | 1 |
| Q1 2026 | 6 | 1 |
| Q4 2025 | 6 | 2 |
| Q3 2025 | 5 | 3 |
| Q2 2025 | 5 | 4 |
| Q1 2025 | 0 | 2 |
| Q4 2024 | 1 | 2 |
| Q3 2024 | 2 | 1 |
| Q2 2024 | 2 | 3 |
Source: Constellation Software Inc. MD&A for the three and nine months ended 30 Sep 2026 (filed 2026-11-06), quarterly organic growth table by revenue type since Q3 2024 and the FX-adjusted companion table (https://www.csisoftware.com/wp-content/uploads/2026/11/CSI-MDA-Q3-2026-Final.pdf); Q3 2026 press release: https://www.csisoftware.com/wp-content/uploads/2026/11/CSI-Press-Release-Q3-2026-Final.pdf. Earlier quarters: MD&A for the three and six months ended 30 Jun 2026, quarterly organic growth table by revenue type since Q2 2024 and the FX-adjusted companion table (https://www.csisoftware.com/wp-content/uploads/2026/08/CSI-MDA-Q2-2026-Final.pdf). Pre-acquisition estimates can be updated in the quarter after close, so this file uses the restated Q2 2026 history rather than originally reported headlines (Q1 2025 headline organic was 0.3% and the restated table prints 0%; Q1 2026 headline FX-adjusted organic was 2% and the restated table prints 1%). Q2 2026 press release: https://www.csisoftware.com/wp-content/uploads/2026/08/CSI-Press-Release-Q2-2026-Final.pdf. The Q3 2026 MD&A reprints Q1 and Q2 2026 unchanged (6%/1% and 3%/1%).
| Period | FX-adjusted maintenance organic growth |
|---|---|
| Q3 2026 | 4 |
| Q2 2026 | 2 |
| Q1 2026 | 4 |
| Q4 2025 | 6 |
| Q3 2025 | 4 |
| Q2 2025 | 6 |
| Q1 2025 | 4 |
| Q4 2024 | 5 |
| Q3 2024 | 6 |
| Q2 2024 | 6 |
Source: Constellation Software Inc. MD&A for the three and nine months ended 30 Sep 2026 (filed 2026-11-06), FX-adjusted quarterly organic growth table by revenue type, Maintenance and other recurring row (https://www.csisoftware.com/wp-content/uploads/2026/11/CSI-MDA-Q3-2026-Final.pdf; same table in the Q3 2026 interim financial report: https://www.csisoftware.com/wp-content/uploads/2026/11/Q3-2026-Shareholder-Report.pdf). Earlier quarters: MD&A for the three and six months ended 30 Jun 2026, FX-adjusted quarterly organic growth table by revenue type, Maintenance and other recurring row (https://www.csisoftware.com/wp-content/uploads/2026/08/CSI-MDA-Q2-2026-Final.pdf). Same table in the Q2 2026 interim financial report (https://www.csisoftware.com/wp-content/uploads/2026/08/Q2-2026-Shareholder-Report.pdf).
| Period | Licenses | Professional services | Hardware and other | Maintenance and other recurring |
|---|---|---|---|---|
| Q3 2026 | 97 | 569 | 131 | 2,715 |
| Q2 2026 | 92 | 573 | 116 | 2,554 |
| Q1 2026 | 91 | 546 | 100 | 2,444 |
| Q4 2025 | 125 | 568 | 138 | 2,346 |
| Q3 2025 | 107 | 538 | 89 | 2,213 |
| Q2 2025 | 87 | 532 | 80 | 2,144 |
| Q1 2025 | 96 | 487 | 74 | 1,996 |
| Q4 2024 | 134 | 524 | 98 | 1,948 |
| Q3 2024 | 84 | 487 | 78 | 1,893 |
| Q2 2024 | 87 | 495 | 68 | 1,819 |
| Q1 2024 | 88 | 470 | 59 | 1,737 |
Source: Constellation Software Inc. MD&A revenue-type tables (USD millions). Q1 2024 and Q1 2025: Q1 2025 MD&A (https://www.csisoftware.com/wp-content/uploads/2026/04/CSI-MDA-Q1-2025-Final.pdf). Q2 2024 year-ago and Q2 2025: Q2 2025 shareholder report (https://www.csisoftware.com/wp-content/uploads/2026/04/Q2-2025-Shareholder-Report.pdf). Q3 2024 year-ago and Q3 2025: Q3 2025 shareholder report (https://www.csisoftware.com/wp-content/uploads/2026/04/Q3-2025-Shareholder-Report.pdf). Q4 2024 year-ago and Q4 2025: FY 2025 MD&A (https://www.csisoftware.com/wp-content/uploads/2026/04/CSI-MDA-Q4-2025-Final.pdf). Q1 2026: Q1 2026 shareholder report (https://www.csisoftware.com/wp-content/uploads/2026/05/Q1-2026-Shareholder-Report.pdf). Q2 2026: Q2 2026 MD&A (https://www.csisoftware.com/wp-content/uploads/2026/08/CSI-MDA-Q2-2026-Final.pdf). Q3 2026: Q3 2026 MD&A, filed 2026-11-06 (https://www.csisoftware.com/wp-content/uploads/2026/11/CSI-MDA-Q3-2026-Final.pdf).
| Period | Cash consideration | Estimated deferred payments |
|---|---|---|
| Q3 2026 | 484 | 125 |
| Q2 2026 | 732 | 160 |
| Q1 2026 | 697 | 112 |
| Q4 2025 | 472 | 99 |
| Q3 2025 | 281 | 134 |
| Q2 2025 | 380 | 89 |
| Q1 2025 | 94 | 39 |
Source: Constellation Software Inc. quarterly earnings-release headlines, acquisitions completed in the quarter (cash consideration including acquired cash, plus estimated deferred payments). Q1 2025 $94 cash + $39 deferred = $133 (https://www.csisoftware.com/constellation-software-inc-announces-results-for-the-first-quarter-ended-march-31-2025-and-declares-quarterly-dividend/). Q2 2025 $380 + $89 = $469 (https://www.csisoftware.com/constellation-software-inc-announces-results-for-the-second-quarter-ended-june-30-2025-and-declares-quarterly-dividend/). Q3 2025 $281 + $134 = $415 (https://www.csisoftware.com/wp-content/uploads/2026/04/CSI-Press-Release-Q3-2025-Final.pdf). Q4 2025 $472 + $99 = $571; FY 2025 annual $1,579 (https://www.csisoftware.com/wp-content/uploads/2026/04/CSI-Press-Release-Q4-2025-Final.pdf). Q1 2026 $697 + $112 = $809 (https://www.csisoftware.com/wp-content/uploads/2026/05/CSI-Press-Release-Q1-2026-Final.pdf). Q2 2026 $732 + $160 = $893 (https://www.csisoftware.com/wp-content/uploads/2026/08/CSI-Press-Release-Q2-2026-Final.pdf). Q3 2026 $484 + $125 = $609 (press release dated 2026-11-06, https://www.csisoftware.com/wp-content/uploads/2026/11/CSI-Press-Release-Q3-2026-Final.pdf).
| Period | CSI excluding Topicus and Lumine | Topicus | Lumine |
|---|---|---|---|
| Q3 2026 | 2,713 | 509 | 290 |
| Q2 2026 | 2,595 | 505 | 235 |
| Q1 2026 | 2,466 | 507 | 208 |
| Q4 2025 | 2,456 | 505 | 216 |
| Q3 2025 | 2,311 | 450 | 187 |
| Q2 2025 | 2,241 | 419 | 184 |
| Q1 2025 | 2,103 | 371 | 179 |
Source: Constellation Software Inc. MD&A supplemental statement of income for Topicus and Lumine, Revenue line, three months then ended (excluding intercompany activity). Q1 2025: Q1 2025 MD&A CSI ex $2,103, Topicus $371, Lumine $179 (https://www.csisoftware.com/wp-content/uploads/2026/04/CSI-MDA-Q1-2025-Final.pdf). Q2 2025: Q2 2025 shareholder report $2,241 / $419 / $184 (https://www.csisoftware.com/wp-content/uploads/2026/04/Q2-2025-Shareholder-Report.pdf). Q3 2025: Q3 2025 shareholder report $2,311 / $450 / $187 (https://www.csisoftware.com/wp-content/uploads/2026/04/Q3-2025-Shareholder-Report.pdf). Q4 2025: FY 2025 MD&A $2,456 / $505 / $216 (https://www.csisoftware.com/wp-content/uploads/2026/04/CSI-MDA-Q4-2025-Final.pdf). Q1 2026: Q1 2026 shareholder report $2,466 / $507 / $208 (https://www.csisoftware.com/wp-content/uploads/2026/05/Q1-2026-Shareholder-Report.pdf). Q2 2026: Q2 2026 MD&A $2,595 / $505 / $235 (https://www.csisoftware.com/wp-content/uploads/2026/08/CSI-MDA-Q2-2026-Final.pdf). Q3 2026: Q3 2026 MD&A, filed 2026-11-06, $2,713 / $509 / $290 (https://www.csisoftware.com/wp-content/uploads/2026/11/CSI-MDA-Q3-2026-Final.pdf).
| Period | CSI excluding Altera | Altera | Consolidated |
|---|---|---|---|
| Q3 2026 | 4 | -8 | 4 |
| Q2 2026 | 4 | -19 | 2 |
| Q1 2026 | 4 | -6 | 4 |
| Q4 2025 | 6 | 5 | 6 |
| Q3 2025 | 5 | -10 | 4 |
| Q2 2025 | 6 | 1 | 6 |
| Q1 2025 | 5 | -9 | 4 |
| Q4 2024 | 6 | -5 | 5 |
| Q3 2024 | 6 | 1 | 6 |
| Q2 2024 | 6 | 7 | 6 |
Source: Q3 2026: Constellation Software Inc. MD&A for the three and nine months ended 30 Sep 2026 (filed 2026-11-06), section Acquisition of business segment from Allscripts Healthcare Solutions, Foreign Exchange Adjusted Organic Revenue Growth table, Maintenance and other recurring row, three months ended 30 Sep 2026, for CSI excluding Altera, Altera and Consolidated (https://www.csisoftware.com/wp-content/uploads/2026/11/CSI-MDA-Q3-2026-Final.pdf; the Q3 MD&A no longer prints the quarterly with/without Altera history table). Earlier quarters: MD&A for the three and six months ended 30 Jun 2026, section Acquisition of business segment from Allscripts Healthcare Solutions, quarterly maintenance and recurring organic growth with and without Altera since Q2 2024 (https://www.csisoftware.com/wp-content/uploads/2026/08/CSI-MDA-Q2-2026-Final.pdf). Same table and the $9 million plus $8 million Q2 2025 Altera notes are in the Q2 2026 interim financial report (https://www.csisoftware.com/wp-content/uploads/2026/08/Q2-2026-Shareholder-Report.pdf). Consolidated column matches the FX-adjusted Maintenance and other recurring row in File 2.